GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,653,196 | +21.6% | 24,276 | -42.7% | 0.00% | 0.0% |
| Q2 2022 | $1,359,859 | +0.0% | 42,386 | +8.4% | 0.00% | 0.0% |
| Q1 2022 | $1,359,214 | +47.4% | 39,118 | +24.9% | 0.00% | 0.0% |
| Q4 2021 | $922,000 | +14.5% | 31,320 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $805,000 | -32.2% | 31,603 | -6.8% | 0.00% | 0.0% |
| Q2 2021 | $1,187,000 | -36.6% | 33,905 | -7.5% | 0.00% | -50.0% |
| Q1 2020 | $1,872,000 | -32.0% | 36,651 | +5.8% | 0.00% | -33.3% |
| Q4 2019 | $2,753,000 | +58.3% | 34,634 | -1.9% | 0.00% | +50.0% |
| Q3 2019 | $1,739,000 | -1.4% | 35,291 | +5.3% | 0.00% | 0.0% |
| Q2 2019 | $1,763,000 | -3.8% | 33,517 | -3.2% | 0.00% | 0.0% |
| Q1 2019 | $1,833,000 | +45.1% | 34,635 | +12.5% | 0.00% | 0.0% |
| Q4 2018 | $1,263,000 | +2.8% | 30,774 | -4.9% | 0.00% | +100.0% |
| Q3 2018 | $1,229,000 | -26.4% | 32,350 | -12.5% | 0.00% | -50.0% |
| Q2 2018 | $1,669,000 | +19.0% | 36,953 | +27.2% | 0.00% | 0.0% |
| Q1 2018 | $1,403,000 | +25.0% | 29,057 | +1.9% | 0.00% | +100.0% |
| Q4 2017 | $1,122,000 | +27.4% | 28,507 | +0.4% | 0.00% | 0.0% |
| Q3 2017 | $881,000 | +11.2% | 28,380 | -2.1% | 0.00% | 0.0% |
| Q2 2017 | $792,000 | +48.6% | 28,978 | +100.3% | 0.00% | 0.0% |
| Q1 2017 | $533,000 | +183.5% | 14,469 | +11.1% | 0.00% | – |
| Q4 2016 | $188,000 | -31.9% | 13,018 | +8.7% | 0.00% | – |
| Q3 2016 | $276,000 | +58.6% | 11,971 | +14.2% | 0.00% | – |
| Q2 2016 | $174,000 | +128.9% | 10,486 | +105.8% | 0.00% | – |
| Q1 2016 | $76,000 | +94.9% | 5,096 | +327.5% | 0.00% | – |
| Q4 2015 | $39,000 | – | 1,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |